Wiley-BlackwellEditor-in-Chief
Graham Jackson, MD, FESC, FRCP, FACC, Consultant Cardiologist, Cardiothoracic Centre, Guy's and St Thomas' Hospital, London, UK
IJCP Team at Wiley-Blackwell - click here
Associate Editors and Editorial Departments
Rheumatology
Karen Costenbader, MD, MPH, Rheumatology and Immunology, Brigham and Women's Hospital, Boston, MA, USA
Cardiovascular Disease Prevention and Metabolic Diseases
Anthony Wierzbicki, FACA, FACB, Senior Lecturer in Chemical Pathology, St. Thomas' Hospital, London, UK
Primary Care & Cardiovascular Medicine
Rubin Minhas, General Practitioner, and Honorary Senior Lecturer with the Faculty of Science, Technology and Medical Studies, University of Kent, UK
Endocrine and Metabolic Diseases
Serge Jabbour, MD, Associate Professor of Clinical Medicine, Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Jefferson Medical College/Thomas Jefferson University, Philadelphia, PA, USA
Diabetes
George Thomson, Chief Medical Officer, The Rotherham NHS Foundation Trust and Honorary Professor, Sheffield Hallam University, UK
Infectious Disease
Richard Stein, MD, PhD, Department of Molecular Biology, Princeton University, One Washington Road, Princeton, NJ 08544, USA
Neurology and Geriatrics
Jagdish C Sharma, Honorary Professor, University of Nottingham & Consultant Physician, Lincoln County Hospital, Lincoln, LN2 5QY, UK
Oncology
Mark Harries, MA, PhD, MRCP, Consultant in Medical Oncology, Guy's Hospital, London, UK
Psychiatry
Leslie Citrome, MD, MPH, Clinical Professor of Psychiatry & Behavioral Sciences at New York Medical College, Valhalla, NY, USA
Urology
Matt Rosenberg, MD, BA, Medical Director, Mid-Michigan Health Centers, Jackson, MI, USA
Respiratory Medicine
Renaud Louis, Professor of Respiratory Medicine, CHU Sart-Tilman LIege Liege, Belgium
Gastroenterology
Peter Irving, Consultant Gastroenterologist, Guy's and St. Thomas' Hospitals, London, UK
Disclosures for Editor-in-Chief and Associate Editors (dated June 2010) - Click Here
Editorial Board
Harold Bays, MD, FACP, Medical Director/President, Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, KY, USA
John Betteridge, MD, PhD, FRCP, Professor of Medicine, Middlesex Hospital, London, UK
Jako Burgers, General Practitioner and Senior Researcher with the Scientific Institute for Quality of Healthcare (IQ Healthcare), Radboud University Nijmegen Medical Centre, The Netherlands
John Chambers, Consultant Cardiologist, St. Thomas' Hospital, London, UK
Roger Chapman, Hepatology and Hepatobiliary Consultant, Experimental Medicine Division, Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK
Christopher Chapple, Consultant Urological Surgeon, Royal Hallamshire Hospital, Sheffield, UK
Andrew Coatesworth, FRCS (ORL HNS), Consultant Otolaryngology/Head and Neck Surgery, York Hospital, York, UK
Gary Das, FRCS, FRCS (Urol), Consultant Urologist, Shirley Oaks Hospital, Croydon, UK
Prokar Dasgupta, MSc (Urol), MD, DLS, FRCS (Urol), FEBU, Consultant and Honorary Senior Lecturer in Urology, Guy's and St Thomas', London, UK
Hans-Christoph Diener, Professor, Chairman, Department of Neurology; Director, Neurological University Clinic, University of Essen, Essen, Germany
Steven J. Edwards, DPhil, Senior Lecturer in the Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK
Edzard Ernst, MD, PhD, FRCP, FRCP (Edin.) Professor, Complementary Medicine Peninsula Medical School, Devon, UK
Ian Fentiman, MD, FRCS, Professor, Consultant Surgeon, Breast Unit, Guy's Hospital, London, UK
Albert Ferro, BSc (Hons), MB, BS, PhD, FRCP, Honorary Consultant in Clinical Pharmacology, King's College London, UK
Jonathan Foulds, PhD, Professor, UMDNJ-School of Public Health, Director, Tobacco Dependence Program, New Brunswick, NJ, USA
Robin Gauld, PhD, Associate Professor of Health Policy, Department of Preventive and Social Medicine, University of Otago Medical School, Dunedin, New Zealand
Paul Giangrande, MD, FRCP, FRCPath, Consultant Haematologist, Oxford Haemophilia Centre, The Churchill Hospital, Oxford, UK
Barry Goldstein, MD, PhD, Director, Division of Endocrinology, Diabetes and Metabolic Diseases, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA
Robin Graham-Brown, FRCP, Consultant Dermatologist, Leicester Royal Infirmary, Leicester, UK
Donald Harrison, MD, Provost for Health Education and Cardiac Pharmacology, University of Cincinnati, Cincinnati, OH, USA
Ted Johnson, MD, MPH, Associate Professor Medicine, Emory School of Medicine, Decatur, GA, USA
Martin Jourdan, MS, FRCS, Consultant Surgeon, London Bridge Hospital, London, UK
George Kassianos, MD, FRCGP, General Medical Practitioner, Wokingham, UK
Michael Kirby, MBBS LRCP MRCS FRCP, Director of HertNet - The Hertfordshire Primary Care Research Network, Letchworth, Herts, UK
Andrew J Larner, Consultant Neurologist, Cognitive Function Clinic Walton, Centre for Neurology and Neurosurgery, Liverpool, UK
Gregory Lip, Consultant Cardiologist and Professor of Cardiovascular Medicine, University of Birmingham Department of Medicine and City Hospital, Birmingham, UK
Renaud Louis MD,PhD, Prof of Respiratory Medicine, University of Liege, CHU Liege, Belgium
Colin Michie, MA, FRCPCH, FLS, FRIPH, Consultant Senior Lecturer in Paediatrics, Ealing Hospital, London, UK
Martin Miner, MD, Men's Health Center, The Miriam Hospital, Brown University, Providence, RI
Mark Nelson, MD, Director of HIV Services, Deputy Director of Research, and Director of HIV Clinical Trials Unit, Chelsea and Westminster Hospital, London, UK
Macaulay Onuigbo, MD, Nephrology, Midelfort Clinic, Mayo Health System, Wisconsin, WI, USA
Bertram Pitt, MD, Professor, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
Stephen Powis, BSc, MRCP, Professor of Renal Medicine, Department of Nephrology, Royal Free Hospital, London, UK
Basant Puri, Professor of Imaging and Psychiatry, Hammersmith Hospital, London UK
John P Reckless, DSc, MD, FRCP, Consultant Physician in Endocrinology and Diabetes, Royal United Hospital, Bath, UK
Grannum R. Sant MD, FRCS,FACS VP US Medical Affairs, Personalized Genetic Health, Cambridge, MA, USA
Naveed Sattar, Professor of Metabolic Medicine, Division of Cardiovascular and Medical Sciences, Glasgow Royal Infirmary, Glasgow, UK
H Ralph Schumacher Jr, MD, Professor of Medicine, Chief in Rheumatology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Chris Simms, D.Phil. School of Health Administration, Dalhousie University, Halifax, Nova Scotia
David R. Staskin, MD, Director, Section of Voiding Dysfunction, St. Elizabeth's Medical Center, Associate Professor of Urology, Tufts University School of Medicine, 736 Cambridge St., Boston, MA 02135
Manouche Tavakoli, MSc, PhD, Director, Department of Management, University of St. Andrews, Fife, UK
David Taylor, MSc, PhD, MRPharmS, Chief Pharmacist, South London and Maudsley NHS Trust, Maudsley Hospital, London, UK
Diethelm Tschöpe, MD, Professor of Medicine (Diabetes), Ruhr-University of Bochum, Heart and Diabetes Centre, North Rhine-Westphalia, Germany
Michael Weinblatt, MD, Professor of Medicine, Rheumatology and Immunology, Brigham and Women's Hospital, Boston, MA, USA
Claus Wendt, PhD, Professor of Sociology of Health and Healthcare Systems, University of Siegen, Siegen, Germany
John Wilding, DM, FRCP, Professor of Medicine & Honorary Consultant Physician, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK